Study ID | Number | Study Title | Institute | Species | Analysis |
---|---|---|---|---|---|
ST000242 | 1 metabolites | Whole unconditioned medium (Defined culture media, M199),Whole M1 medium,Whole M2 medium | Mayo Clinic | Homo sapiens | MS |
ST000403 | 1 metabolites | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Monash University | Homo sapiens | MS |
ST000539 | 1 metabolites | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Monash University | Homo sapiens | MS |
ST000546 | 1 metabolites | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Monash University | Plasmodium falciparum | MS |
ST000974 | 1 metabolites | GC6-74 matabolomic of TB (Part 1: Plasma) | Max Planck Institute for Infection Biology | Homo sapiens | MS |
ST000976 | 1 metabolites | GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Max Planck Institute for Infection Biology | Homo sapiens | MS |
ST001175 | 1 metabolites | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Monash University | Plasmodium falciparum | MS |
ST001201 | 1 metabolites | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001202 | 1 metabolites | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001204 | 1 metabolites | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001205 | 1 metabolites | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001232 | 1 metabolites | Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria | Pennsylvania State University | Plasmodium Falciparum | MS |
ST001274 | 1 metabolites | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Monash University | Trypanosoma brucei brucei | MS |
ST001304 | 1 metabolites | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Monash University | Toxoplasma gondii | MS |
ST001384 | 1 metabolites | Plasmodium falciparum increased time in circulation underlies persistent asymptomatic infection in the dry season | Penn State | Homo sapiens | MS |
ST001547 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages | Monash University | Homo sapiens | MS |
ST001548 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-II) | Monash University | Homo sapiens | MS |
ST001549 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-III) | Monash University | Homo sapiens | MS |
ST001660 | 1 metabolites | Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors | Pennsylvania State University | Plasmodium falciparum | MS |
ST001788 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Monash University | Homo sapiens | MS |
ST001835 | 1 metabolites | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Idaho Veterans Research and Education Foundation | Homo sapiens | MS |
ST001873 | 1 metabolites | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Dalian Institute Of Chemical Physics | Homo sapiens | MS |
ST001874 | 1 metabolites | Metabolomics analysis of multiple samples on Agilent 6546-Part 1 | Dalian Institute Of Chemical Physics | Homo sapiens | MS |
ST001875 | 1 metabolites | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Dalian Institute Of Chemical Physics | Mus musculus | MS |
ST001876 | 1 metabolites | Metabolomics analysis of multiple samples on Agilent 6546-Part 2 | Dalian Institute Of Chemical Physics | Mus musculus | MS |
ST001897 | 1 metabolites | A local source of insulin in the eye governed by phagocytosis and starvation | University of Virginia | Mus musculus | MS |
ST001983 | 1 metabolites | Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines | University of Oklahoma Health Sciences Center | Homo sapiens | MS |
ST001985 | 1 metabolites | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Pennsylvania State University | Plasmodium falciparum | MS |
ST002010 | 1 metabolites | Chemoresistant Ovarian Cancer Global Metabolomics | The University of South Australia | Homo sapiens | MS |
ST002011 | 1 metabolites | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Pennsylvania State University | Plasmodium falciparum | MS |
ST002024 | 1 metabolites | Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption | Pennsylvania State University | Plasmodium falciparum | MS |
ST002078 | 1 metabolites | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Pennsylvania State University | Plasmodium falciparum | MS |
ST002094 | 2 metabolites | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Mayo Clinic | Homo sapiens | MS |
ST002104 | 1 metabolites | Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations | Future Industries Institute | Homo sapiens | MS |
ST002106 | 1 metabolites | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) | Monash University | Plasmodium falciparum | MS |
ST002107 | 1 metabolites | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Monash University | Plasmodium falciparum | MS |
ST002108 | 1 metabolites | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Monash University | Plasmodium falciparum | MS |
ST002234 | 1 metabolites | A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis | CRG | Homo sapiens | MS |
ST002322 | 1 metabolites | Metabolomics study comparing SCAP KO and WT B cells | Indiana University School of Medicine | Mus musculus | MS |
ST002493 | 1 metabolites | Composition of raw plant-based food items Pilot Study | Massachusetts Institute of Technology | Malus domestica/Solanum lycopersicum/Lactuca sativa/Fragaria x ananassa/Allium sativum/Ocimum basilicum | MS |
ST002555 | 1 metabolites | Ethnicity-Specific Differences in Ovarian Cancer Metabolic Signatures | University of Oklahoma Health Sciences Center | Homo sapiens | MS |
ST002792 | 1 metabolites | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Monash University | Plasmodium falciparum | MS |
ST002926 | 1 metabolites | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Monash University | Plasmodium falciparum | MS |
ST003066 | 1 metabolites | Heritability of RBC metabolites: baseline correlation of metabolites and markers of RBC health and stability | University of Iowa | Homo sapiens | MS |
ST003160 | 1 metabolites | New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites | Monash University | Plasmodium falciparum | MS |